Health ❯Mental Health ❯Schizophrenia
Personal Stories Stigma Reduction Impact on Behavior Cobenfy Antipsychotic Medications Public Awareness Drug Efficacy Clinical Trials
AbbVie's emraclidine failed to meet key endpoints in Phase 2 trials, impacting its $8.7 billion acquisition of Cerevel Therapeutics.
